|
?:abstract
|
-
Human Novel Coronavirus (ncovid-19) is an important pathogen globally In the days and weeks ahead, we expect to see the number of cases, the number of deaths, and the number of affected countries climbs even higher We have therefore made the assessment that COVID-19 characterized as a pandemic This review provides a comprehensive, up-to-date assessment on current issues of the basic virology, pathogenesis, clinical epidemiology, and laboratory features, treatment and prevention strategies for ncovid-19 However, current evidences on ncovid-19 demonstrate that these viruses effectively spread via infected droplets, aerosols, contacts, hands and surfaces It is transmitted between individuals Previously, two coronaviruses infecting animals have evolved and caused outbreaks in humans i e SARS-cov (Severe Acute Respiratory Syndrome) and MERS-cov (Middle East Respiratory Syndrome) Coronavirus is responsible for a substantial proportion of upper respiratory tract infections These viruses traditionally associated with dry cough, cold, shortness of breath, sore throat and fever So, optimal treatment involves prompt diagnosis and it is slightly manageable with current technologies Indeed, whether the clinical manifestations of coronavirus are related directly to viral pathogenicity or secondary to the host immune response is the subject of ongoing research There are currently no approved antiviral therapies and treatment remains primarily supportive Pharmacists are a trusted and accessible resource for the public during this public health emergency Role of pharmacists is to ensure the availability and timely provision of the safest and most effective therapy in pandemic disease Copyright © Journal of Global Trends in Pharmaceutical Sciences
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}